Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5132182 | 0.95 | LMNA (0.51) | LMNATSHRTDP1KMT2AKDM4E | |
| SCHEMBL27893206 | 0.94 | NAAA (0.52) | LMNATSHRTDP1KMT2AKDM4E | |
| SCHEMBL1395745 | 0.94 | NAAA (0.52) | LMNATSHRTDP1KMT2AKDM4E | |
| SCHEMBL5662533 | 0.94 | NAAA (0.52) | LMNATSHRTDP1KMT2AKDM4E | |
| SCHEMBL27811461 | 0.94 | NAAA (0.52) | LMNATSHRTDP1KMT2AKDM4E | |
| SCHEMBL28495462 | 0.92 | NAAA (0.51) | LMNATSHRTDP1KMT2AKDM4E | |
| SCHEMBL28237089 | 0.92 | NAAA (0.51) | LMNATSHRTDP1KMT2AKDM4E | |
| SCHEMBL28693859 | 0.92 | NAAA (0.51) | LMNATSHRTDP1KMT2AKDM4E | |
| SCHEMBL11047101 | 0.92 | NAAA (0.51) | LMNATSHRTDP1KMT2AKDM4E | |
| SCHEMBL28237215 | 0.92 | NAAA (0.51) | LMNATSHRTDP1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12194020-B2 | Reversing baldness through cannabinoid receptor activation | POSTREL RICHARD (US) | 2025-01-14 | — | — | US | claimed |
| EP-3856213-B1 | METHODS OF TREATMENT OF INFECTIONS USING BACTERIA | INDAPTUS THERAPEUTICS INC (US) | 2024-03-06 | — | — | EP | claimed |
| US-20220249434-A1 | Reversal of Baldness in Men and Women through Cannabinoid Receptor Activation | POSTREL RICHARD (US) | 2022-08-11 | — | — | US | claimed |
| US-20220031768-A1 | METHODS OF TREATMENT OF INFECTIONS USING BACTERIA | INDAPTUS THERAPEUTICS, INC. | 2022-02-03 | — | — | US | claimed |
| US-11147844-B2 | Methods of treatment of infections using bacteria | DECOY BIOSYSTEMS, INC. (US) | 2021-10-19 | — | — | US | claimed |
| EP-3856213-A1 | METHODS OF TREATMENT OF INFECTIONS USING BACTERIA | Decoy Biosystems, Inc. (US) | 2021-08-04 | — | — | EP | claimed |
| WO-2020069211-A1 | METHODS OF TREATMENT OF INFECTIONS USING BACTERIA | DECOY BIOSYSTEMS, INC. (US) | 2020-04-02 | — | — | WO | claimed |
| US-20200101119-A1 | METHODS OF TREATMENT OF INFECTIONS USING BACTERIA | INDAPTUS THERAPEUTICS, INC. | 2020-04-02 | — | — | US | claimed |
| US-20200078333-A1 | Healthier Aging in Domesticated Animals | POSTREL RICHARD (US) | 2020-03-12 | — | — | US | claimed |
| US-20190290614-A1 | Methods for Reducing Recurrence of Tumors | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 2019-09-26 | — | — | US | claimed |
| US-20190029993-A1 | QUALITY OF LIFE EXTENSION THERAPIES RELATING TO AGING, FOOD ALLERGIES, PAIN AND REDUCED VIGOR BY MANAGING MOLECULAR, CELLULAR AND SUBCELLULAR BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OTHER ORGANELLE PROCESSES | REVIGORON LLC | 2019-01-31 | — | — | US | claimed |
| US-20190030044-A1 | HUMAN LIFE EXTENSION THERAPY THROUGH MOLECULAR, CELLULAR AND SUBCELLULAR MANAGEMENT OF BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OF OTHER ORGANELLE PROCESSES ASSOCIATED WITH THE ADVENT OF DISEASE AND/OR AGING | POSTREL RICHARD (US) | 2019-01-31 | — | — | US | claimed |
| WO-2018118197-A1 | HEALTHIER AGING IN DOMESTICATED ANIMALS | POSTREL RICHARD (US) | 2018-06-28 | — | — | WO | claimed |
| WO-2018089467-A1 | METHODS FOR REDUCING RECURRENCE OF TUMORS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2018-05-17 | — | — | WO | claimed |
| US-8980851-B2 | Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway | ACCELALOX, INC. (US) | 2015-03-17 | — | — | US | claimed |
| US-20050143356-A1 | Selective inhibition of cyclooxygenase 1 in the treatment of diabetic nephropathy | VANDERBILT UNIVERSITY | 2005-06-30 | — | — | US | claimed |
| EP-1126835-A1 | METHOD FOR PREVENTING INCREASED IRIDIAL PIGMENTATION DURING PROSTAGLANDIN TREATMENT | Synphora AB (SE) | 2001-08-29 | — | — | EP | claimed |
| WO-2000025771-A1 | METHOD FOR PREVENTING INCREASED IRIDIAL PIGMENTATION DURING PROSTAGLANDIN TREATMENT | SYNPHORA AB (SE) | 2000-05-11 | — | — | WO | claimed |
| EP-4619016-A1 | TREATMENT OF CANCERS AND INFECTIOUS DISEASES WITH KILLED INTACT BACTERIA | Indaptus Therapeutics, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| WO-2000025771-A1 | METHOD FOR PREVENTING INCREASED IRIDIAL PIGMENTATION DURING PROSTAGLANDIN TREATMENT | SYNPHORA AB (SE) | 2000-05-11 | — | — | WO | disclosed |